+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Overview: Flutiform

  • PDF Icon


  • 17 Pages
  • February 2018
  • Region: Global
  • Citeline
  • ID: 4533474
Drug Overview

Flutiform ([fluticasone propionate + formoterol fumarate]; Vectura/Mundipharma/Kyorin) is a pressurized metered-dose inhaler formulation which contains a combination of fluticasone propionate and formoterol. Fluticasone propionate is an inhaled corticosteroid which has potent anti-inflammatory activity when delivered by inhalation, while formoterol fumarate is a long-acting beta 2 agonist which acts as a bronchodilator.

Table of Contents

Product Profiles
Flutiform: Asthma

List of Figures
Figure 1: Asthma - current and future market dynamics analysis
Figure 2: Drug assessment summary of Flutiform in asthma
Figure 3: Drug assessment summary of Flutiform in asthma

List of Tables
Table 1: Flutiform drug profile
Table 2: Flutiform pivotal trial data in asthma
Table 3: Flutiform Phase III trials in asthma
Table 4: Flutiform sales for asthma across Japan and the five major EU markets, by country ($m), 2017-26